Bloomios

Bloomios Long-term Debt

The Long-Term Debt of Bloomios (BLMS) as of Nov 5, 2026 is 150,000.00 USD. In the previous year, Long-Term Debt was 150,000.00 USD — a change of 0.00% (lower).

Long-term Debt

150,000.00USD

YoY

0.00%

Last updated:

Long-Term Debt of Bloomios is 2022 150,000.00 USD. Long-Term Debt of Bloomios was 2021 150,000.00 USD. It decreases by 0.00% lower compared to the previous year.

The Bloomios Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2019
40,800.00 USD
Jan 1, 2020
831,000.00 USD
Jan 1, 2021
150,000.00 USD
Jan 1, 2022
150,000.00 USD
The Bloomios Long-term Debt history
YEARLong-term DebtYoY
150,000.00USD0.00%
150,000.00USD-81.95%
831,000.00USD+1,936.76%
40,800.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bloomios Stock analysis

What does Bloomios do? Bloomios, Inc. generates revenue through the wholesale distribution of U.S. hemp-derived supplements and cosmetic products. The company manufactures and distributes hemp-infused edibles, pet edibles, tinctures, shots, topicals, smokable hemp, and other products across seven categories including edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. BPL, a subsidiary of Bloomios, focuses on manufacturing and distributing hemp-derived nootropic and nutraceutical products to wholesalers and retailers. Bloomios provides private-label and white-label services with over 80 customizable products and custom formulation and manufacturing support for its customers. The company's primary customers are wholesalers and retailers who purchase its hemp-derived products for resale. Bloomios offers a comprehensive suite of services including custom formulation, order fulfillment, and brand development to support its clients. Its product portfolio spans multiple categories such as human edibles, pet edibles, liquid consumables, topicals, and smokable hemp, catering to both consumer and pet markets. Bloomios leverages its subsidiary BPL to expand its product offerings in the hemp-derived nootropic and nutraceutical sectors. The company's focus on customizable solutions allows it to serve a diverse range of clients seeking private-label and white-label hemp products. Through its wholesale distribution channels, Bloomios targets businesses looking to sell hemp-based supplements and cosmetics under their own brand names. Bloomios is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bloomios stock

Long-Term Debt of Bloomios is 150,000.00 USD in 2022.

Long-Term Debt of Bloomios changed from 150,000.00 USD to 150,000.00 USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Bloomios since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Bloomios historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Bloomios

All Key Metrics — Bloomios